Exhibitor Details

Back

ASPIRE PHARMACEUTICALS PRIVATE LIMITED

ASPIRE PHARMACEUTICALS PVT.LTD. PLOT NO. I-3/12, INDUSTRIAL AREA, SECTOR-5 NAYA RAIPUR,
WWW.ASPIREPHARMACEUTICALS.CO.IN

Product Categories

Formulations
ACECLOFENAC (100 MG)+ PARACETAMOL (325 MG),ACETYL SALICYLIC (75MG) + CLOPIDOGREL (75MG),Adapalene(0.1%)+Clindamycin1%,ALBENDAZOLE (200 MG),ALBENDAZOLE (400 MG),ALUMINIUM HYDROXIDE (6 GM) + DIMETHICONE (100 MG) + DIPHENHYDRAMINE (12.5 MG),AMBROXOL (15 MG) + DEXTROMETHORPHAN (10 MG) + CETIRIZINE (5 MG),AMLODIPINE (10 MG),ATORVASTATIN (10 MG),ATORVASTATIN (20 MG),ATORVASTATIN (40 MG),AZITHROMYCIN (250 MG),AZITHROMYCIN (500 MG),BECLOMETASONE (0.025%) + CLOTRIMAZOLE (1%),BECLOMETHASONE (0.025%) + NEOMYCIN (0.5)+ CLOTRIMAZOLE (1%),CALCIUM (500 MG) + VITAMIN D3 (0.25 MCG),CETIRIZINE (10 MG),CHLORPHENIRAMINE (4 MG) + DEXTROMETHORPHAN (10 MG),CIPROFLOXACIN (250 MG),CIPROFLOXACIN (500 MG),CIPROFLOXACIN (500 MG) + TINIDAZOLE (600 MG),CLOPIDOGREL (75 MG),CLOTRIMAZOLE (1%),CLOTRIMAZOLE (100 MG),CLOTRIMAZOLE (2%),CO-TRIMOXAZOLE (240 MG) + TRIMETHOPRIM (40 MG) + SULPHAMETHOXAZOLE (NA),DICLOFENAC (50 MG),DICLOFENAC (50 MG) + PARACETAMOL (325 MG),DICLOFENAC (50 MG) + PARACETAMOL (500 MG) + SERRATIOPEPTIDASE (15 MG),DICLOFENAC (NA) + PARACETAMOL (NA),DICYCLOMINE (10 MG) + MEFENAMIC ACID (250 MG),DICYCLOMINE (20 MG) + PARACETAMOL (325 MG),DULOXETINE (20 MG),ELEMENTAL IRON (50 MG) + FOLIC ACID (0.5 MG),ESOMEPRAZOLE (40 MG),ETIZOLAM (1 MG),FEXOFENADINE (120 MG),FLUCONAZOLE (150 MG),FLUCONAZOLE (200 MG),GLIMEPIRIDE (1 MG) + METFORMIN (1000 MG),GLIMEPIRIDE (1 MG) + METFORMIN (500 MG),GLIMEPIRIDE (2 MG) + METFORMIN (1000 MG),GLIMEPIRIDE (2 MG) + METFORMIN (500 MG),HYDROQUINONE (4%) + MOMETASONE (0.1%) + TRETINOIN (0.025%),IBUPROFEN (100 MG) + PARACETAMOL (162.5 MG),IBUPROFEN (200 MG),IBUPROFEN (400 MG),IBUPROFEN (400 MG) + PARACETAMOL (325 MG),IBUPROFEN (600 MG),ITRACONAZOLE (1%) + CLOBETASOL (0.05%) + OFLOXACIN (0.75%) + ORNIDAZOLE (2%),KETOCONAZOLE (200 MG),KETOCONAZOLE (NA),LEVETIRACETAM (250 MG),LEVETIRACETAM (500 MG),LEVETIRACETAM (750 MG),LEVOCETIRIZINE (5 MG),LEVOFLOXACIN (500 MG),LINAGLIPTIN (5 MG),LOSARTAN (50 MG) + HYDROCHLOROTHIAZIDE (12.5 MG),LULICONAZOLE (40 MG),METFORMIN (1000 MG),METFORMIN (500 MG),Metformin(850mg),METRONIDAZOLE (200 MG),METRONIDAZOLE (400 MG),METRONIDAZOLE (NA),MICONAZOLE (2%),MOMETASONE (0.1%),MONTELUKAST (10 MG),MONTELUKAST (10 MG) + LEVOCETIRIZINE (5 MG),MULTIVITAMINS (NA) + MINERALS (NA),OFLOXACIN (200 MG),OFLOXACIN (NA) + ORNIDAZOLE (500 MG),ONDANSETRON (2 MG),ONDANSETRON (4 MG),ONDANSETRON (8 MG),PANTOPRAZOLE (20 MG),PANTOPRAZOLE (40 MG),PARACETAMOL (250 MG),PARACETAMOL (500 MG),PARACETAMOL (650 MG),PARACETAMOL (NA) + PHENYLEPHRINE (NA) + CHLORPHENIRAMINE (NA),PHENYLEPHRINE (NA) + CPM (NA) + DEXTROMETHORPHAN (NA),PREGABALIN (75 MG) + NORTRIPTYLINE (10 MG),RABEPRAZOLE (20 MG),ROSUVASTATIN (10 MG),ROSUVASTATIN (20 MG),ROSUVASTATIN (40 MG),SILDENAFIL (100 MG),SILDENAFIL (50 MG),SITAGLIPTIN (100 MG),SITAGLIPTIN (50 MG),SITAGLIPTIN (50 MG) + METFORMIN (1000 MG),SITAGLIPTIN (50 MG) + METFORMIN (500 MG),TELMISARTAN (20 MG),TELMISARTAN (40 MG),TELMISARTAN (80 MG),TENELIGLIPTIN (20 MG),TERBINAFINE (1%) + MOMETASONE (0.1%),VILDAGLIPTIN (50 MG),VILDAGLIPTIN (50 MG) + METFORMIN (1000 MG),VILDAGLIPTIN (50 MG) + METFORMIN (500 MG)

Company Profile

ASPIRE PHARMACEUTICALS PRIVATE LIMITED, FOUNDED IN 2020 AND HEADQUARTERED IN RAIPUR, CHHATTISGARH, IS A PREMIER PHARMACEUTICAL FORMULATION AND MANUFACTURING COMPANY DEDICATED TO ITS VISION OF “CRAFTING HEALTHIER TOMORROWS.” THE COMPANY OPERATES A STATE-OF-THE-ART MANUFACTURING FACILITY IN NAVA RAIPUR, ENGINEERED TO COMPLY WITH RIGOROUS CGMP, REVISED SCHEDULE M, EUGMP, PIC/S, AND USFDA STANDARDS. SPECIALIZING IN THE DEVELOPMENT AND PRODUCTION OF TABLETS, CAPSULES, LIQUID ORALS (SYRUPS AND SUSPENSIONS), AND SEMI-SOLID FORMULATIONS, ASPIRE IS BACKED BY DEDICATED PACKAGING, QUALITY CONTROL, MICROBIOLOGY, AND R&D INFRASTRUCTURE. DRIVEN BY A CORE COMMITMENT TO QUALITY, REGULATORY COMPLIANCE, AND CUSTOMER SATISFACTION, ASPIRE SERVES ESTEEMED PHARMACEUTICAL ENTERPRISES, GOVERNMENT BODIES, AND INSTITUTIONAL CLIENTS .THE COMPANY CONTINUOUSLY ADVANCES ITS MANUFACTURING CAPABILITIES AND QUALITY ASSURANCE SYSTEMS TO DELIVER SAFE, EFFECTIVE, AND CONSISTENTLY SUPERIOR PHARMACEUTICAL SOLUTIONS.